Previous 10 | Next 10 |
Rosh Pinna, Israel, Aug. 30, 2022 (GLOBE NEWSWIRE) -- (“ IR-MED or the “ Company ”) ( OTCQB: IRME) , an innovative medical device company that is developing non-invasive, real-time detection devices utilizing Infra-Red light spectroscopy (IR) and Artific...
IR-MED ( OTCQB:IRME ) said on Friday it had submitted a new provisional patent application covering new methods relating to its non-invasive device, PressureSafe, for detecting and classifying early-stage pressure injuries (PI). The company's PressureSafe device is c...
Rosh Pinna, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) -- (“ IR-MED or the “ Company ”) ( OTCQB: IRME) , an innovative medical device company, developing non-invasive, real-time detection devices that utilize Infra-Red light spectroscopy (IR) and Artificial ...
Rosh Pinna, Israel, June 23, 2022 (GLOBE NEWSWIRE) -- (“ IR-MED or the “ Company ”) ( OTCQB: IRME) , an innovative development stage medical device company that utilizes Infra-Red light spectroscopy (IR) combined with Artificial Intelligence (AI) technol...
IR-Med (“ IR-MED or the “ Company ”) ( OTCQB:IRME) , an innovative development-stage medical device company utilizing Infra-Red light spectroscopy (IR) and Artificial Intelligence (AI) technologies to develop non-invasive detection devices, today announc...
IR-Med (OTCPK:IRME) entered into subscription agreements with certain investors for the sale of 3.64M shares at $0.88/share and warrants to purchase additional shares at $1.1/share. The company received total gross proceeds of $3.2M. Proceeds to be used for general corporate purposes and to a...
IR-Med (“ IR-MED or the “ Company ”) ( OTCQB:IRME) , an innovative development stage medical device company that utilizes Infra-Red light spectroscopy (IR) combined with Artificial Intelligence (AI) technologies, announced that it has entered into a Subs...
IR-Med (“ IR-Med or the “ Company ”) ( OTC:IRME) is pleased to announce that IR-Med has been approved by OTC Markets to up-list from Pink Sheet to the OTCQB tier after IR-Med satisfied the required uplist criteria. Effective as of February 1 st , 202...
IR-Med (OTC: IRME) (“Company” or “the Company”) is proud to announce a series of corporate updates to its investors regarding the medical, financial, and corporate status of the company. Amongst other things, IR-Med announces that starting H1 of 2022 the Comp...
New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME). Our non-invasive monitoring technology enters the public eye – why I’m so excited for 2022. Dear new, old, and prospective IR-Med shareholders, Welcome to IR-MED. After months...
News, Short Squeeze, Breakout and More Instantly...
IR-Med Inc Company Name:
IRME Stock Symbol:
OTCMKTS Market:
Poster presentation available here: LINK Rosh Pina, Israel, May 22, 2024 (GLOBE NEWSWIRE) -- IR-MED Inc. , (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis t...
By Thomas Kerr, CFA IR-Med (OTC: IRME) released its annual 10-K filing on April 1, 2024 and the results were largely in line with expectations. The...
Marks major milestone prior to launch in U.S. market PressureSafe ™ s canner and disposable pack both listed with FDA PressureSafe ™ can support early detection of pressure injuri...